{"organizations": [], "uuid": "b1d89ef32088b22716decee137acde44b8bad415", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180302.html", "section_title": "Archive News &amp; Video for Friday, 02 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/elekta-results/update-1-elekta-ab-q3-profit-orders-top-forecasts-cuts-full-year-margin-forecast-idUSL8N1QK0V0", "country": "US", "domain_rank": 408, "title": "UPDATE 2-Elekta shares jump on forecast-beating Q3 earnings", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-02T15:08:00.000+02:00", "replies_count": 0, "uuid": "b1d89ef32088b22716decee137acde44b8bad415"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/elekta-results/update-1-elekta-ab-q3-profit-orders-top-forecasts-cuts-full-year-margin-forecast-idUSL8N1QK0V0", "ord_in_thread": 0, "title": "UPDATE 2-Elekta shares jump on forecast-beating Q3 earnings", "locations": [], "entities": {"persons": [{"name": "richard hausmann", "sentiment": "none"}], "locations": [], "organizations": [{"name": "elekta", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "(Adds shares, CEO comment)\nMarch 2 (Reuters) - Swedish radiation therapy equipment maker Elekta on Friday reported above-forecast earnings and order intake for its fiscal third quarter, sending shares higher and outweighing a cut margin forecast for the full year.\n* Q3 ‍gross order intake was 3,833 million SEK ($465 million), up 9 percent based on constant exchange rates, and far above a 3,288 million mean analyst forecast\n* Q3 ‍EBITA (earnings before interest, tax and amortization), adjusted for items affecting comparability and bad debt losses, rose to 502 million from 325 million in the year-ago quarter, beating a 483 million average analyst forecast in a Reuters poll\n* Elekta shares rise as much as 11 percent in early trading, up 8 percent at 0719 GMT\n*“I am very pleased with the quarterly performance. We delivered a strong quarter, and even more importantly we continued to build a solid foundation for future growth,” Chief Executive Richard Hausmann told Reuters ​\n* Says ‍we remain committed to reaching an EBITA margin of over 20 percent, but cuts expectation for current fiscal year to around 19 percent\n* The company had been targeting an EBITA margin of more than 20 percent in fiscal year 2017/18​\n* The average analyst forecast was for a full year EBITA margin of 19.4 percent\n* Elekta says lower margin target due to less favourable FX effects and the impact from a previously announced launch delay of its new radiation therapy machine Unity\n* Elekta counts U.S. firm Varian Medical Systems as its main rival\n* Its shares were up 11 percent YTD until Thursday’s close, double the gain for Varian, and sharply outperforming a 6 percent drop in the STOXX Europe 600 Healthcare Index ​\n* Says two new Elekta Unity orders were booked in quarter. The new machine is seen as an important future growth-driver​ Source text for Eikon: Further company coverage: ($1 = 8.2484 Swedish crowns) (Reporting by Johannes Hellstrom; Editing by Simon Johnson)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-02T15:08:00.000+02:00", "crawled": "2018-03-03T17:28:44.077+02:00", "highlightTitle": ""}